Amdocs Limited (DOX)
Chart Events
Performance Outlook
| Previous Close | 75.62 |
| Open | 76.44 |
| Bid | 77.94 x 1300 |
| Ask | 77.94 x 2200 |
| Day's Range | 76.03 - 78.13 |
| 52 Week Range | 54.68 - 82.38 |
| Volume | 722,588 |
| Avg. Volume | 987,622 |
| Market Cap | 10.191B |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | 15.30 |
| EPS (TTM) | 5.09 |
| Earnings Date | Aug 03, 2021 - Aug 09, 2021 |
| Forward Dividend & Yield | 1.44 (1.90%) |
| Ex-Dividend Date | Mar 30, 2021 |
| 1y Target Est | 84.17 |
Fair Value
Related Research
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amdocs Limited of Class Action Lawsuit and Upcoming Deadline – DOX
NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX), and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 21-cv-03078, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Amdocs ordinary shares between December 13, 2016 and March 30, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Amdocs ordinary shares during the Class Period, you have until June 8, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Amdocs, through its global subsidiaries, provides software and services to communications, cable and satellite, entertainment, and media industry service providers worldwide. Historically, the Company’s largest percentage of revenues come from its North American business, mostly the U.S., particularly from large customers including, among others, AT&T Inc. (“AT&T”). The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Amdocs overstated its profits, cash, and liquidity, while understating its debt; (ii) Amdocs concealed its large borrowing; (iii) while Amdocs’ reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times. On March 31, 2021, pre-market, Jehoshaphat Research published a short-seller report addressing Amdocs, which alleged, inter alia, that Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; that there was a concerning pattern of reputable auditors resigning, only to be replaced by “scandal-plagued or tiny shops”; that Amdocs “window-dressed” its balance sheets to keep its large borrowing a secret, namely by paying down its debt just prior to the end of each quarter, therefore showing a debt-free balance sheet on that day, before re-borrowing the money shortly thereafter; and that all of the foregoing was corroborated by former employees and direct competitors of the Company, who noted that Amdocs was losing AT&T as a customer, as well as a former American Amdocs executive, who stated that the Company’s “US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable.” On this news, Amdocs’ ordinary share price fell $9.19 per share, or 11.58%, to close at $70.15 per share on March 31, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com888-476-6529 ext. 7980
- GlobeNewswire
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DOX, FGEN, GOEV, VRM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Vroom, Inc. (VRM)Class Period: 6/9/2020 - 3/3/2021Lead Plaintiff Motion Deadline: May 21, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-vrm/ Canoo Inc. (GOEV, GOEVW)Class Period: 8/18/2020 - 3/29/2021Lead Plaintiff Motion Deadline: June 1, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-goev/ Amdocs Limited (DOX)Class Period: 12/13/2016 - 3/30/2021Lead Plaintiff Motion Deadline: June 8, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-dox/ FibroGen, Inc. (FGEN)Class Period: 10/18/2017 - 4/6/2021Lead Plaintiff Motion Deadline: June 11, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-fgen/ If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above. If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline. About KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana. To learn more about KSF, you may visit www.ksfcounsel.com. Contact: Kahn Swick & Foti, LLCLewis Kahn, Managing Partnerlewis.kahn@ksfcounsel.com1-877-515-18501100 Poydras St., Suite 3200New Orleans, LA 70163
- Newsfile
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amdocs Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2021 - DOX
New York, New York--(Newsfile Corp. - May 14, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Amdocs Limited ("Amdocs") (NASDAQ: DOX) between December 13, 2016 and March 30, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information ...
- BLU FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - BLUNewsfile
- SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against PureCycle Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire
